top of page
ResQ Biotech
Home: Welcome
Advancing early-stage drug

ResQ Biotech

​

Advancing early-stage drug discovery for diseases caused by protein misfolding and aggregation

Protein Misfolding diseases

ResQ Biotech's targets include notorious diseases such as Alzheimer's disease and amyotrophic lateral sclerosis

Our Platform Technology

Our technology enables the rapid production and screening of vast molecular libraries for identifying drug leads against various protein misfolding diseases

Our Pipeline

ResQ Biotech has several ongoing research programs focused on protein misfolding diseases

Research tools

ResQ Biotech has developed proprietary tools for basic and applied research

NEws

Get the latest news on ResQ Biotech's activities

Scientist

CONTACT US

Patras Science Park & National Hellenic Research Foundation

Thanks for submitting!

  • Black LinkedIn Icon
bottom of page